Related Experiment Video
Updated: Jun 4, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Case report: A single novel calpain 3 gene variant associated with mild myopathy
Sara Massucco1, Paola Fossa2, Chiara Fiorillo3
1Department of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal and Child Health (DiNOGMI), University of Genoa, Genova, Italy.
Abstract:
Recessively inherited limb-girdle muscular dystrophy type 1, caused by mutations in the calpain 3 gene, is the most common limb-girdle muscular dystrophy worldwide. Recently, cases of autosomal dominant calpainopathy have been described. A man was referred to our neurological outpatient clinic at the age of 54 for persistent hyperCKemia (>1000 U/l) associated with muscle fatigue and myalgia. Clinical examination revealed mild proximal weakness in the lower limbs. His brother exhibited a moderate increase in serum creatine kinase levels (up to 2000 U/l) without other signs of myopathy. Their father experienced slowly progressive lower limb weakness after the age of 50. The calpain 3 variant c.1478G>A (p.Arg493Gln) in the heterozygous state was identified in both brothers. In silico modeling studies predict that this substitution may disrupt protein folding. This represents the first description of the heterozygous p.Arg493Gln calpain 3 variant as a potential cause of mild calpainopathy.
Insights
Autosomal dominant calpainopathy, a rare form of limb-girdle muscular dystrophy, can be caused by heterozygous mutations in the calpain 3 gene. This study identifies a novel variant potentially leading to mild symptoms.
Area of Science:
- Neurology
- Genetics
- Biochemistry
Background:
- Limb-girdle muscular dystrophy type 1 (LGMD1) is typically recessive, caused by calpain 3 gene mutations.
- Autosomal dominant forms of calpainopathy are increasingly recognized.
- Calpain 3 is crucial for muscle function.

